Esophageal squamous cell carcinoma (ESCC) is a common malignancy worldwide and
often diagnosed at advanced stages with poor prognosis. Combination of radiotherapy and …

Importance Esophageal cancer (EC) is the 7th most common cancer worldwide and 14th in
the US. More data are needed to study the changing incidence patterns of its 2 primary …

Background To evaluate the efficacy and safety of toripalimab combined with neoadjuvant
chemoradiotherapy (NCRT) for locally advanced esophageal squamous cell carcinoma …

FOLFOX regimen, composed of folinic acid, 5-fluorouracil (5-FU) and oxaliplatin (OXP), has
been used as clinical standard therapeutic regimen in treatments of colorectal cancer (CRC) …

Introduction Esophageal cancer (EC), particularly esophageal squamous cell carcinoma
(ESCC), is characterized by high incidence and poor prognosis worldwide, necessitating …

Background Oesophageal squamous cell carcinoma (ESCC) is a lethal malignancy.
Immune checkpoint inhibitors (ICIs) showed great clinical benefits for patients with ESCC …

Neoadjuvant immunochemotherapy (nICT) has dramatically changed the treatment
landscape of operable esophageal squamous cell carcinoma (ESCC), but factors …

With the advent of immune checkpoint inhibitors (ICIs), a better understanding of tumor
microenvironment (TME) is becoming crucial in managing esophageal squamous cell …

Background The morbidity and mortality rates of esophageal squamous cell carcinoma
(ESCC) are high in China. The overall survival (OS) of patients with ESCC is related to …

Objective To establish the life expectancy burden of esophago‐gastric cancer by analyzing
years of life lost (YLL) for a Western patient population after treatment of early esophageal …